Comparison · September 2026
NAD+ vs glutathione
Two unrelated molecules that share a drip menu and one awkward property: neither enters a cell intact, so what is being bought is raw material rather than the molecule on the label.
Boards for the compounds on this page: NAD+, Glutathione.
At a glance
| Dimension | NAD+ | Glutathione |
|---|---|---|
| What it is | A coenzyme every cell uses to move electrons during energy metabolism. | A three-amino-acid molecule cells make for themselves and use to neutralize reactive compounds. |
| What it does inside a cell | Carries electrons between reactions, and acts as a consumable substrate for several repair and signaling enzymes. | Donates an electron to a reactive molecule, and tags foreign compounds so the body can clear them. |
| What happens when it is injected | It is taken apart by enzymes on the cell surface and rebuilt inside from the fragments. | It is cut into its component amino acids outside the cell, and cells rebuild it internally from those parts. |
| Where the human evidence actually sits | Mostly with oral precursors, and mostly on whether a blood measurement rises rather than whether anyone improves. | With controlled trials in specific clinical settings that have nothing to do with the wellness claims. |
| Evidence grade | Limited evidence. The category grade, earned by the precursor research rather than by the drip. | Limited evidence. Real biology and real trials elsewhere, none supporting what it is sold for here. |
| Regulatory position | No FDA-approved product exists. What is sold is a compounded preparation, under rules that are unsettled. | No FDA-approved injectable exists. Glutathione appears in an approved US product only as a component of a surgical irrigating solution. |
| What buyers usually get sold | Energy, brain fog, recovery and slowing aging. | Detoxification, skin brightening and antioxidant support. |
Evidence grade
NAD+
Glutathione
Where a compliant provider sells this today
NAD+
Trellis Vitality ranks highest of 14 providers on this board. $129/mo — per month, protocol
Trellis Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Trellis Vitality See the full NAD+ boardGlutathione
Trellis Vitality ranks highest of 8 providers on this board. $93/mo — per month, protocol
Trellis Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Trellis Vitality See the full Glutathione boardThe short answer
These two are not versions of each other and they are not a stack with a shared rationale. NAD+ is a coenzyme that shuttles electrons through metabolism. Glutathione is a small peptide that gives an electron away to neutralize something reactive.
They share a drip menu, a price structure and a vocabulary. They do not share a mechanism, a target or a body of evidence.
They do share one structural problem, and it is the most useful thing on this comparison. Neither molecule is taken into a cell whole. Both are broken down outside the cell and rebuilt inside from the pieces, which means an injection of either supplies raw material rather than the finished molecule the label advertises.
What NAD+ is for
NAD+ is a coenzyme, which means an enzyme cannot do its job without it. Its main role is to accept and release electrons, cycling between two forms as metabolism runs. That cycling is why the molecule is described as central to energy production.
A second role is what makes it interesting to the longevity market. Several enzyme families, including those involved in DNA repair and in cellular signaling, consume NAD+ rather than merely borrowing it. Those families spend it, so supply matters in a way it does not for a pure carrier.
That is a genuine reason to ask the question the category asks. It is not by itself an answer, and the difference between the two is the whole of what follows.
What glutathione is for
Glutathione is built from three amino acids and is made inside cells, continuously, by two enzymes working in sequence. It is one of the most abundant small molecules in the body, and its concentration inside a cell is far higher than anything circulating in blood.
It does two jobs. It hands an electron to reactive molecules that would otherwise damage cell components, and it attaches itself to foreign compounds so the body has a handle to clear them by. The second job is the real process the word detox gestures at.
The word does a lot of unearned work in marketing. A conjugation reaction is a defined chemical step with a defined product. It is not a general cleansing, and describing it that way turns a measurable process into a promise nobody can check.
The shared problem: neither one goes in whole
Cell membranes do not admit either molecule intact. NAD+ is large and carries charge, and enzymes on the cell surface dismantle it before anything is absorbed. The fragments are taken up and used to rebuild NAD+ inside.
Glutathione meets the same wall by a different route. An enzyme on the outside of cells cleaves it, the resulting amino acids are taken up, and the cell reassembles glutathione internally using its own machinery.
So both injections are, mechanically, deliveries of parts. That does not make either pointless, because supplying parts can matter when parts are the limiting factor. It does mean the mental image being sold — topping up a tank of the molecule itself — describes something that does not happen.
Where each one’s real human evidence lives
For NAD+, the published human work sits mainly with oral precursors rather than with injections or drips. That research has repeatedly shown a measurable rise in the marker it targets, and has been much thinner on whether people feel or function differently.
For glutathione, controlled human trials do exist, and they are in clinical settings: cardiac procedures, circulation disorders, neurological conditions. Those studies asked medical questions about patients with specific problems.
Neither body of work supports the claims on the menu. Evidence does not travel from a cardiology trial to a wellness drip, and a marker rising in a precursor study is not a person improving. Both compounds sit in the limited tier for exactly that reason, and neither earned it from the route being sold.
The precursor asymmetry
One difference between the two is worth knowing, because it cuts against the drip in both cases.
Raising glutathione by supplying its building block is established medicine. Acetylcysteine is an approved injectable drug, and its whole mechanism is providing the cysteine that glutathione synthesis depends on. It is used as an antidote for acetaminophen overdose, where glutathione depletion is the problem being solved.
That is the strongest demonstration anywhere that increasing glutathione can matter clinically, and it works through a precursor rather than through glutathione itself. NAD+ research has followed the same shape, with the oral precursors carrying most of the human data. In both categories, the route with the best evidence is not the route being sold at a premium.
Where the regulatory question sits
Neither compound has an FDA-approved product behind the use it is marketed for. What is dispensed through these programs is compounded, and which substances may be compounded is unsettled.
Glutathione has one distinguishing detail. It does appear in an approved US drug product, but as one component of a sterile irrigating solution used during eye surgery. That is a very long way from an injectable wellness preparation, and a seller pointing at any approval should be read against what the approval actually covers.
A compounded preparation has not been reviewed by the FDA for safety, effectiveness or manufacturing quality, whatever an individual pharmacy’s own standards are. That describes the review pathway, not an allegation about any pharmacy.
How the grades were set
Both compounds carry the limited tier, and in both cases the grade rewards mechanism rather than marketed outcomes. The biology is real, it has been measured in people, and the thing being promised has not been.
Neither grade is a safety finding, and neither is a claim that the underlying science is weak. The chemistry of both molecules is settled and well described. The missing step is the one between chemistry and a result somebody would notice.
A grade moves when randomized, placebo-controlled trials appear in people resembling the buyers, measuring outcomes those buyers would recognize, through the route actually being sold. Trials in a different population, or on a different route, do not move it.
Key takeaways
- NAD+ is an electron-carrying coenzyme; glutathione is a three-amino-acid molecule that neutralizes reactive compounds. They share a menu, not a mechanism.
- Neither molecule enters a cell intact. Both are broken down outside and rebuilt inside from their parts.
- The human evidence for NAD+ sits mainly with oral precursors, and mostly measures a marker rather than an outcome.
- Glutathione has controlled human trials in cardiac, circulatory and neurological settings, none of which supports the wellness claims.
- Acetylcysteine, an approved injectable that supplies glutathione’s building block, is the strongest clinical case that raising glutathione can matter — through a precursor, not the molecule itself.
- Glutathione appears in an approved US drug product only as a component of a surgical irrigating solution.
Frequently asked questions
Should I take NAD+ or glutathione?
That question assumes the two are alternatives, and mechanically they are not. NAD+ is a coenzyme that carries electrons through metabolism and is consumed by repair and signaling enzymes. Glutathione is a small peptide that donates an electron to reactive molecules and tags foreign compounds for clearance. They act in different places on different chemistry. Neither has published outcome evidence for the wellness uses they are sold on, so nothing supports ranking one above the other, and any dose decision belongs with a prescriber rather than a comparison page.
Do these two work better together?
No published controlled trial has tested the combination in people for the uses being marketed. Both are frequently offered in the same bag or the same plan, which reflects how clinics build menus rather than any finding about the pair. Combining two compounds that individually lack outcome evidence produces a broader claim, not a better-supported one. The pairing does make the pitch sound more thorough, and that is a marketing effect rather than a pharmacological one.
If glutathione is an antioxidant, does an injection reduce oxidative stress?
Antioxidant describes a chemical behavior — donating an electron to something reactive — not a health outcome. Glutathione does that reliably in a test tube and inside a cell. The step nobody has demonstrated for the marketed use is that raising it by injection changes anything a person would notice. There is also the delivery problem: injected glutathione is cleaved outside cells and rebuilt inside from the amino acids, so the molecule arriving is not the molecule doing the work.
Is there an FDA-approved glutathione injection?
No. Glutathione appears in an approved US drug product only as one component of a sterile irrigating solution used in eye surgery, which is a different product for a different purpose. Injectable glutathione sold through wellness programs is a compounded preparation, and compounded status is not approval. A seller referencing an approval is pointing at something that does not cover what is in the syringe.
Why does glutathione get a limited grade if the wellness claims are unsupported?
Because the tier describes the weight of the human evidence behind the compound, and glutathione has controlled human trials — in cardiac procedures, circulation disorders and neurological conditions. Those are real studies asking real clinical questions, and they are the reason the grade is not the lowest tier. They also have nothing to do with detoxification, skin brightening or energy. The grade recognizes that a serious literature exists while the page states clearly that it does not reach the marketing.
Why does the delivery route keep coming up?
Because for both of these molecules the route determines what actually arrives. Neither crosses a cell membrane intact, so both are dismantled outside the cell and reassembled inside from the fragments. That makes an intravenous line a faster way into the bloodstream rather than a way into a cell, which is the thing the marketing implies. For both compounds, the research with the most human data behind it uses precursors, and that is the opposite of what the premium route promises.